Search results for: Policy Analysis
Filter search results
Managed Care – An Option for the German Health Care System?
1 April 1998
…and which Germany may one day employ have been termed a ‘managed care revolution’. In Germany’s debate over its future health policy, while reform proposals along managed care lines have…
How can HTA meet the needs of health system and government decision makers?
4 January 2017
The 2015 meeting of the HTAi Asia Policy Forum meeting was held in Singapore, 29th -30th October 2015. The topic of the meeting was: How can HTA meet the needs…
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
1 July 2019
…should pay for new medicines, in order to reward and incentivise innovation, has become a crucial question for policy makers. Another important question that has gained attention of all stakeholders…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
8 January 2020
…policy hurdles related to evidence development and acceptance, value assessment and reimbursement pathways,… Histology independent therapies, a new class of medicines that target cancer based on specific genomic or molecular…
Lou Garrison
30 August 2023
…peer-reviewed journals. His research interests include national and international health policy issues related to personalized medicine, benefit-risk analysis, insurance, pricing, reimbursement, and risk-sharing agreements, as well as the economic evaluation…
OHE’s AMR consultation response
21 November 2023
…et al., 2022; Leonard et al., 2023). Policy solutions for this market failure have been proposed in various forms. Once such solution involves the use of pull incentives which present…
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
…a first-of-its-kind analysis of adult immunisation programmes by the Office of Health Economics (OHE) and commissioned by IFPMA (1), looked at four adult vaccines across ten countries where they are…
Dr Tina Wang
11 November 2024
…Chemistry from the Beijing University of Technology and a Master of Science in Pharmaceutical Analysis and Quality Control from Kings College, University of London. Tina completed her PhD at the…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…can help to achieve the necessary policy changes. To account for broader potential of LA therapies, HTA frameworks need to adapt by incorporating broader value elements and leveraging real-world evidence….